Atenolol in hypertension: a double-blind comparison of the response to three different doses. 1977

F J Zacharias, and P J Hayes, and J M Cruickshank

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082

Related Publications

F J Zacharias, and P J Hayes, and J M Cruickshank
January 1989, Therapie,
F J Zacharias, and P J Hayes, and J M Cruickshank
October 1990, Journal of human hypertension,
F J Zacharias, and P J Hayes, and J M Cruickshank
November 1988, Southern medical journal,
F J Zacharias, and P J Hayes, and J M Cruickshank
August 1995, QJM : monthly journal of the Association of Physicians,
F J Zacharias, and P J Hayes, and J M Cruickshank
July 1981, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
F J Zacharias, and P J Hayes, and J M Cruickshank
May 1985, American heart journal,
F J Zacharias, and P J Hayes, and J M Cruickshank
April 1979, British journal of clinical pharmacology,
F J Zacharias, and P J Hayes, and J M Cruickshank
January 1979, British journal of clinical pharmacology,
F J Zacharias, and P J Hayes, and J M Cruickshank
June 1987, International journal of clinical pharmacology, therapy, and toxicology,
F J Zacharias, and P J Hayes, and J M Cruickshank
May 1987, The American journal of cardiology,
Copied contents to your clipboard!